Tech Stocks
Technology stocks have been top performers over the past decade, handily outpacing the broader market. Our technology stock investing coverage provides investors with guidance, analysis and recommendations on the tech sector. We dig into the financials, growth trajectories and market opportunities for leading technology stocks.
With names like Apple, Microsoft, Amazon and Alphabet dominating the markets, tech stocks are impossible for investors to ignore. The technology sector accounts for over 25% of the S&P 500’s total value. We help investors understand the forces shaping winners and losers in this transformational sector.
From e-commerce and cloud computing to semiconductor chips and cybersecurity, game-changing tech trends create huge potential for stock upside. Yet picking long-term winners presents challenges, with tech company fortunes changing quickly. Our technology stock analysis aims to identify established leaders and emerging disruptors with durable competitive advantages.
Beyond mega-cap tech stocks, we also provide coverage of less-followed small and mid-cap names operating under the radar. These rapidly-growing tech stocks can handily outperform with the right catalysts. We provide tech investors diversified stock ideas across market caps and sub-sectors.
While tech stocks carry higher risk, they have also produced spectacular rewards over time. By staying on the cutting edge of tech stock news and analysis, our coverage pinpoints opportunities while assessing downside hazards.
Koil Energy’s 41% Annual Surge: Is it Time to Invest?
Koil Energy Solutions, Inc. (KLNG) has seen its shares increase by 41.2% over the past year, outperforming the alternative energy industry’s growth of 26.3%. ...
Oak Valley Bancorp’s 26% Annual Growth: Is It a Buy Opportunity?
Oak Valley Bancorp (OVLY) has seen its shares increase by 25.9% over the past year, outpacing the banking industry’s growth of 18.7%. In comparison, ...
Implications of the BATTMAN Trial for mCRC: AGEN BOT+BAL Analysis
Agenus Inc. (AGEN) is advancing a phase III study called BATTMAN, targeting its combination therapy of botensilimab and balstilimab (BOT+BAL) for refractory microsatellite stable ...
Navigating Agenus Stock: Assessing Valuation and Funding Challenges
Agenus Inc. (AGEN) is advancing its lead immuno-oncology program, BOT+BAL, in a Phase III study for refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) ...
AGEN Early Access Revenue Highlights Promising Future Before Approval
Agenus Inc. (AGEN) is utilizing authorized access routes to validate the demand for its lead immuno-oncology combination, botensilimab plus balstilimab (BOT+BAL), prior to traditional ...
ICLR Earnings Shift: Insights from the Accounting Investigation
**ICON plc (ICLR) Faces Earnings and Credibility Reset** ICON plc is undergoing a significant credibility and earnings reset due to accounting issues, with projections ...
Cencora’s Specialty Supply Chain: Charting the Future of COR’s Expansion
Cencora, Inc. (COR) is shifting its focus from traditional pharmaceutical distribution to higher-value services aimed at enhancing therapy delivery reliability. Notably, the company now ...
Top Dividend Stocks to Consider for June 5th
**Stocks with Strong Income Characteristics – June 5, 2023** On June 5, 2023, Zacks Investment Research highlighted three stocks characterized by a strong buy ...
Is Now the Time to Invest in Capstone After a 109% Year-to-Date Surge?
Capstone Energy+, Inc. (CGEH) shares surged 109.1% year-to-date, vastly outperforming the alternative energy sector’s 17% growth. In contrast, competitors Ocean Power Technologies, Inc. (OPTT) ...
Integer Holdings 2026 Forecast: Key Factors, Challenges, and Valuation Insights
Integer Holdings Corporation (ITGR) has revised its outlook for 2026, forecasting organic sales to be flat or decrease by 1%. The new revenue projections ...












